Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
15. Dezember 2020 07:55 ET
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Karamedica Announces National Institute of Aging Grant to Develop Microparticle Therapy for Cerebral Amyloid Angiopathy (CAA)
10. Oktober 2018 08:00 ET
|
Karamedica, Inc.
RALEIGH, N.C., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Karamedica, Inc., a start-up biomedical company, recently received a Small Business Innovative Research (SBIR) grant from the National Institute of...